Mupirocin (Mup) is a topical antibacterial agent that interferes with protein synthesis by competitively inhibiting bacterial isoleucyl-tRNA synthetase (11, 19) . A 2% Mup calcium ointment (Bactroban Nasal; GlaxoSmithKline) applied topically to the anterior nares eradicates carriage of Staphylococcus aureus and prevents infection in certain settings (2, 7, 8, 13 ). An important concern, however, is the development of Mup resistance (Mup r ) (14, 17) , of which there are two types. Lowlevel Mup r (MIC, 8 to 256 mg/liter) is usually associated with a mutation in the gene for target enzyme, while high-level Mup r (Hi-Mup r ) (MIC, Ͼ256 mg/liter) is mediated by a plasmid containing the ileS2 gene that encodes an additional isoleucyl-tRNA synthetase enzyme (3). Such transmissible resistance raises concern about the spread of Mup r as Mup usage becomes more widespread (9, 10, 17) . The objectives of this study were to determine (i) the prevalence of Mup r in methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) isolates from nasal samples; (ii) the location, if present, of the ileS2 gene in Mup r isolates; and (iii) the organism genotype, as defined by pulsed-field gel electrophoresis (PFGE).
Nasal samples submitted to the Clinical Microbiology Laboratory of the Hospital Universitario Doce de Octubre for isolation of S. aureus between October 2001 and October 2002 were included in the study. Specimens were obtained from two groups. Group I comprised adults who underwent elective heart surgery, before which a sample from the anterior nares was taken to determine whether the patient was a carrier of S. aureus. Group II included all new cases of MRSA infection diagnosed at the hospital that were associated with concurrent nasal carriage. Since 1996, we have instituted the use of topical Mup ointment to reduce the prevalence of nasal MRSA. Samples were inoculated onto phenol-red mannitol salt agar plates that were incubated at 37°C for 48 h. Isolation and identification of S. aureus were based upon standard microbiological procedures. All isolates were screened for resistance to Mup on Mueller-Hinton agar with a 5-g disk (Oxoid). A zone of inhibition Յ 13 mm in diameter was considered to reflect Mup r (5). Mup r organisms underwent MIC analysis by the E-test strip method (AB Biodisk). Susceptibility testing with other antibiotics was performed by disk diffusion (12, 16) . All isolates were confirmed as MRSA by PCR detection of the mecA gene (6) . PCR was also performed on all Mup r isolates to detect the plasmid-associated ileS2 gene (1) .
Mup r isolates were typed by PFGE following DNA extraction and digestion with SmaI (4). Restriction fragments were separated in a CHEF DRIII PFGE system (Bio-Rad Laboratories). Migration of DNA fragments was normalized using an appropriate size marker. Computer-assisted analysis of PFGE patterns was carried out using GelCompar software (Applied Maths). PFGE types (designated by letters) differed by Ͻ7 fragments, while subtypes (designated by Arabic numerals) had indistinguishable patterns (15) . Plasmid DNA was extracted by a rapid minipreparation procedure (QIAprep spin plasmid kit from Qiagen) and digested with HindIII. Southern blot analysis of PFGE-separated SmaI digests of genomic DNA and HindIII plasmid fragments was performed with an ECL system (Amersham) using a 456-bp PCR-amplified ileS2 gene fragment as a probe.
Among patients in group I, S. aureus was isolated from 159 of 689 (23%) (Fig. 2) . Most Hi-Mup r MRSA isolates of PFGE type A (9 of 13, 69%) carried the ileS2 probe region on the 4.5-kb fragment, as did the only Hi-Mup r MSSA isolate (PFGE type C) ( Fig. 1 and 2) . No positive results were observed in Southern blot analysis of PFGE-separated SmaIdigested genomic DNA. This is because the ileS2-containing plasmids (even prior to digestion with SmaI) are smaller than can be detected at the lower limit of resolution and migrate out of the gel during the course of electrophoresis.
We identified four MRSA-infected patients with nasal colonization by Mup-susceptible (Mup s ) organisms; Mup r bacteria were subsequently isolated (isolates 5, 12, 14, and 15) from these patients 7 to 30 days after intranasal application of Mup ointment ( Table 1 ). The Mup s and Mup r isolates from three of the four patients were of the same PFGE subtype, while in the case of the fourth patient there was a difference of a single band (Fig. 1) . In these patients, Mup treatment probably exerted selective pressure for organisms which had preexisting high-level resistance and which subsequently recolonized their nasal passages (18) . We detected a much higher percentage of Mup r among isolates of MRSA (14.8%) than among isolates of MSSA (0.6%). Two epidemiological phenomena probably contribute to Hi-Mup r in S. aureus. First, Southern blots of plasmid DNA located the ileS2 resistance gene on two different plasmid fragments, indicating that at least two plasmids or plasmid variants harbor this gene. One of these variants was implicated in horizontal gene transfer and spread of Hi-Mup r between MRSA and MSSA. This was demonstrated by the identification of a 4.5-kb ileS2-hybridizing plasmid fragment in two isolates (one of MRSA and the other of MSSA) with distinctly different PFGE genotypes. Second, identification of the same PFGE subtypes and ileS2 hybridization and antibiotic resistance patterns among Hi-Mup r isolates ( 
